Report Categories
View AllRecent Articles
View All
Ellington Financial EFC Surges 079 Nearing 1411 Resistance 20260518
NewAmsterdam NAMSW Stalls at 2731 Consolidation Phase 20260518
Empresa EDN Stock Analysis Climbs 107 Eyes on 2380 20260518
Range RNGT Flat at 1007 Consolidation Continues 20260518
Hub Cyber HUBCZ Unchanged at 001 RangeBound Trading 20260518
Whats Next for NewGenIvf NIVFW at 002 20260518
The Simply SMPL Jumps 121 on Strong Momentum 20260518
Cloudastruct CSAI Jumps 093 on Strong Momentum 20260518
Celcuity CELC Down 496 How Low Could It Go 20260518
Hertz HTZ Down 651 How Low Could It Go 20260518
Genmab AS GMAB Stock Today Drops 055 Key Support at 2507 20260518
Willis WLFC Stock Consolidating at 17991 Next Move Ahead 20260518
Cartesian 3W CGCTW Stock Analysis Climbs 351 Eyes on 124 20260518
Seneca Foods SENEB Stock Today Rallies 281 Resistance at 14978 20260518
Northwest NWN Surges 265 Nearing 5219 Resistance 20260518
Omega Flex OFLX Stock Analysis Climbs 052 Eyes on 2860 20260518
Why McKesson Corporation MCK Just Surged 200 Key Levels Ahead 20260518
Bluerock RE BPRE Jumps 257 on Strong Momentum 20260518
Lifezone LZM Fell 429 Is a Recovery Ahead 20260518
Autohome ATHM Drops 164 Key Support at 1593 20260518
Is Beazer Homes BZH Still a Buy After 140 Rally 20260518
Entergy ENJ Stock Analysis RangeBound Near 2010 20260518
Calisa Right ALISR Unchanged at 051 RangeBound Trading 20260518
Highland HFRO Flat at 616 Consolidation Continues 20260518
Franklin FTF Stock Today Unchanged at 587 Key Levels 20260518
Research REFR Stock Analysis Falls 063 Watching 076 20260518
Is INNOVATE VATE Still a Buy After 328 Rally 20260518
GigCapital8 GIW Steady at 1003 Awaiting Next Catalyst 20260518
Bragg Gaming BRAG Stock Up 976 Key Resistance at 189 20260518
First FR Rallies 092 as Bulls Target 6446 20260518
HubSpot HUBS Climbs 423 Resistance at 21711 in Focus 20260518
Why Cerence CRNC Just Surged 082 Key Levels Ahead 20260518
Pelican PELI Stock Today Drops 1179 Key Support at 782 20260518
Prestige PBH Trading at 4662 Key Decision Point 20260518
Prenetics PRENW Stock Analysis Flat at 002 Whats Next 20260518
Arqit Quantum ARQQW Surges 811 Nearing 008 Resistance 20260518
Is Belite Bio BLTE Undervalued at 14248 20260518
Inogen INGN Stock Consolidating at 638 Next Move Ahead 20260518
Unisys UIS Jumps 100 on Strong Momentum 20260518
AGNC Pref G AGNCL at 2490 Buy Sell or Hold 20260518
External Links
SNC Scandic Coin Debuts on Multiple Exchanges as Regulated RealWorld Asset Token
IMUX Q1 2026 Earnings Wider Loss Than Expected but Stock Gains on Pipeline Momentum
Chco Stock Analysis City Holding Company 1.42 Percent Gain 121.22 Price Regional Bank Outlook 20260401 1
NTCL Surges 488 as Trading Activity Picks Up Key Levels in Focus
Renaissance Technologies Takes Stake in United Therapeutics A Look at the Biotech Play
Smallcap Stocks Outperform Nifty 50 Bajaj Finserv AMC Points to Potential Entry Opportunity
AN2 Therapeutics ANTX Slides 27 as Shares Test Support Near 427
RMBI Q1 2026 Earnings Solid EPS Performance Amid Quiet Quarter
Atlanticus Holdings Corporation ATLCL Q1 2026 Earnings Strong EPS Beat Drives Solid Performance
800 Billion AI Spending Fuels GDP and Stock Market Gains as Real Wages Stagnate Consumer Spending Weakens
Trump Promotes Palantir on Truth Social After Disclosure of Stock Transactions
Invx Stock Analysis Innovex International Inc Up 0.95 Percent At 24.46 In Trade 20260403 1
UPXI Q1 2026 Earnings Massive EPS Miss Sends Stock Lower
How Stock SYBT cash generation compares to earnings SYBT Quarterly Earnings Stock Posts Loan Growth Amid Rate Challenges
SpaceX Potential IPO A Look at Historys Biggest Stock Market Debuts
Palantir Stock Receives Lift From Dells Strong Earnings Report
TOVX Q1 2026 Earnings Narrowerthanexpected loss reported stock declines 819
Jyong Biotech Ltd MENS Stabilizes Near Key Support After Modest Uptick
ERIC Ericsson American Depositary Shares notches 20 percent Q1 2026 EPS beat but stock falls 65 percent amid lingering growth concerns
US Government Stake Speculation Intensifies Traders Eye IonQ Micron Anduril as Potential Next Targets